Trial ID or NCT#

NCT02346253

Status

RECRUITING

Purpose

This phase I/II trial studies the side effects and how well high-dose brachytherapy works in treating patients with prostate cancer that has not spread to other parts of the body. Brachytherapy is a type of radiation therapy in which radioactive material sealed in needles, seeds, wires, or catheters is placed directly into or near a tumor and may be a better treatment in patients with prostate cancer.

Official Title

A Phase I/II Study of High-Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer

Eligibility Criteria

Sexes Eligible for Study: Male
Accepts Healthy Volunteers: No

Investigator(s)

Mark K Buyyounouski, MD, MS
Genitourinary specialist, Radiation oncologist
Associate Professor of Radiation Oncology (Radiation Therapy) at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

Madelyn Kissel
(650) 497-8966